**Anthem Biosciences Set to Make a Splash on the Stock Market**
**IPO Success: Strong Demand and High Subscription Rate**
Anthem Biosciences is all set to make its debut on the stock exchanges on Monday, July 21, and the signs are looking promising. The company’s IPO, which closed on July 16, saw an overwhelming response from investors, with a subscription rate of 67.42 times the offered shares.
**Grey Market Signals Point to a Strong Listing**
Grey market signals are indicating a potential 29% listing gain over the IPO price of Rs 570. This is a significant indicator of the market’s confidence in the company’s prospects and a strong start to its journey as a publicly traded entity.
**Who Led the Charge?**
The strong demand for Anthem Biosciences’ IPO was led by Qualified Institutional Buyers (QIBs), who subscribed to the issue 192.80 times. Non-Institutional Investors (NIIs) and retail investors also showed significant interest, with subscription rates of 44.70 times and 5.98 times, respectively.
**A Rs 3,395 Crore OFS-Only Issue**
Anthem Biosciences’ IPO was an Offer for Sale (OFS) only issue, which means that the company did not raise any fresh capital. Instead, existing shareholders sold their shares to the public, raising a total of Rs 3,395 crore in the process.
**What’s Next?**
With its successful IPO and promising grey market signals, all eyes are on Anthem Biosciences as it begins its journey as a listed company. Will it continue to ride the wave of investor enthusiasm? Only time will tell, but for now, the signs are looking good.
